PDI inks deal with 'top-five' pharma company

Share this article:
PDI has inked a deal with an undisclosed “top-five pharmaceutical company” expected to generate $23 million in revenue for the contract sales firm over its one-year term. PDI said the deal will target primary care physicians and specialty audiences.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions